To determine whether perlecan is required for the acute neuroprotective effects of IL-1α after stroke, we used a perlecan hypomorph (pln KO) mouse that expresses 10% of normal total perlecan levels (and hence 10% of normal total perlecan LG3; complete perlecan knockout mice are embryonic lethal). Here, IL1A is linked to stroke disorder.